FDA NDC Directory · JSON-LD · Markdown

ALYMSYS

NDC 70121-1754 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namebevacizumab-maly
Labeler / ManufacturerAmneal Pharmaceuticals LLC
Marketing categoryBiologic License Application · App BLA761231
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsBEVACIZUMAB (100 mg/4mL)
Marketing started20220415
Marketing ended20281031
Package count1

External sources

Source: openFDA. Public-domain (CC0).